The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms

Author:

Porreca Ann Marie,Sullivan Kaede V.,Gallagher Jason C.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Reference93 articles.

1. •• Ben-David D, Kordevani R, Keller N, Tai I, Marzel O, Gal-Mor Y, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2017;18(1):54–60. https://doi.org/10.1111/j.1469-0691.2011.03478.x. This article illustrated the impact that carbapenem-resistant K. pneumoniae had on mortality in patients with bloodstream infections.

2. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099–106. https://doi.org/10.1086/592412 .

3. •• World Health Organization. Global Antimicrobial Resistance Surveillance System. Manual for Early Implementation. WHO. 2015:1–44. http://www.who.int/drugresistance/en/%5Cnwww.who.int/about/licensing/copyright_form/en/index.%5Cnhttp://apps.who.int/iris/bitstream/10665/188783/1/9789241549400_eng.pdf?ua=1. This reference is important because it emphasized the current emergence of Klebsiella pneumoniae carbapenemases globally.

4. • Centers for Disease Control and Prevention. Tracking CRE. CDC. 2017;2010:2009–10. https://doi.org/10.1086/668770 . This report revealed that all states, with exception of Maine and Idaho, reported cases of Klebsiella pneumoniae carbapenemase-producing organisms

5. • Pitout JDD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873–84. https://doi.org/10.1128/AAC.01019-15 . This paperrevealed how ST258 predominates in the United States and around the world, suggesting a possible selective or fitness advantage over other clones

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3